Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO
- 1 January 2006
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 12 (6) , 492-500
Abstract
The chemokine receptor CXCR4 regulates neuronal survival and differentiation and is involved in a number of pathologies, including cancer and human immunodKeywords
This publication has 49 references indexed in Scilit:
- Localization of the κ Opioid Receptor in Lipid RaftsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor InternalizationMolecular Pharmacology, 2006
- CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cellsJournal of Cell Science, 2006
- Morphine Potentiates HIV‐1 gp120–Induced Neuronal ApoptosisThe Journal of Infectious Diseases, 2005
- Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseasesBrain Research Reviews, 2005
- Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal ratsDevelopmental Brain Research, 2004
- Role of the α‐chemokine stromal cell‐derived factor (SDF‐1) in the developing and mature central nervous systemGlia, 2003
- Inverse agonists and neutral antagonists at µ opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependenceJournal of Neurochemistry, 2001
- Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical μ-opoid receptorNeuropharmacology, 1999
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998